ACTRN12610000669099
Recruiting
未知
A pilot study on the safety and effectiveness of the Ligation of Intersphincteric Fistula Tract (LIFT) procedure as a treatment for fistula-in-ano.
Dr Peter Lee0 sites20 target enrollmentAugust 16, 2010
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Fistula-in-ano
- Sponsor
- Dr Peter Lee
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •i)Patients with cryptoglandular or Crohn's fistula
- •ii)Patients deemed inappropriate for fistulotomy or patients with complex fistulae, as defined by recurrent fistula, fistula involving \> 30\-50% of external sphincter, anterior fistula in a female patient and fistula in a patient with existing incontinence
- •iii) Ability to provide informed consent
Exclusion Criteria
- •Exclusion criteria are:
- •i) Patients with fistula related to pouch surgery
- •ii) Patients who are unable to provide informed consent to participation
- •iii) Patients who are unable to comply with follow up requirements
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Safety and Efficacy of the Adapt Pericardial Patch in the repair of defects associated with congenital heart disease in participants aged between 1 and 12 years of ageCongenital Heart Disease including ventricular septal defect repair, atrial ventricular septal defect, atrio ventricular septal defects as determined by clinical assessment including MRI and echo cardiographyCardiovascular - Other cardiovascular diseasesACTRN12613000308796A/Professor Christian Brizard40
Recruiting
Phase 1
Investigation of fractional CO2 laser and adipose tissue exosome in the treatment of acne scars and skin rejuvenatioCondition 1: Skin aging. Condition 2: Atrophic scar.Atrophic disorder of skinScar conditions and fibrosis of skinL90.9L90.5IRCT20200127046282N52Tehran University of Medical Sciences16
Active, not recruiting
Not Applicable
A pilot study to examine the efficacy and safety of escitalopram in doses up to 50 mg for the treatment of patients with Major Depressive Disorder (MDD). - Resistant Depression StudyMajor Depressive DisorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2008-003359-58-GBCPS Research60
Completed
Phase 2
A pilot study to explore the efficacy and safety of jam oral immunotherapy with hypoallergenized cow's milk for children with cow's milk allergyfood allergy (cow's milk)JPRN-UMIN000018372ational Center for Child Health and Development10
Completed
Not Applicable
Safety and efficacy of Transcend CyPass glaucoma implant in open angle glaucoma patients who have failed medical treatmentPrimary open angle glaucomaEye DiseasesGlaucomaISRCTN23263504Transcend Medical, Inc.™ (USA)20